Randomized placebo-and active controlled study of eplivanserin, a novel sleep agent, on next-day psychomotor and cognitive tasks in healthy subjects

被引：0
|
作者：
Micallef-Roll, J.
Roy, C.
Delfolie, A.
Pinquier, J. L.
Blin, O.
机构：
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2009年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
544
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [21] A randomised, double-blind, placebo-controlled, single-dose, crossover, pilot study investigating the effects of cannabinol (CBN) 30 mg and 300 mg on sleep architecture and next-day function in insomnia disorder ("CUPID" study)
    Lavender, Isobel
    Marshall, Nat
    McGregor, Iain
    Grunstein, Ron
    Yee, Brendon
    Hoyos, Camilla
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [22] Interobserver and interequipment variability of transcutaneous hepatic arterial Doppler sonography: A randomized, blinded and placebo controlled study with the ultrasound contrast agent SHU 508A in healthy and cirrhotic subjects.
    Huebner, GH
    Kuehne, I
    Reimann, A
    Steudel, N
    Schaerff, K
    Kleber, G
    Lotterer, E
    Fleig, WE
    HEPATOLOGY, 1999, 30 (04) : 570A - 570A
  • [23] Minimal Influence of Formulated Nutritional Interventions on Sleep and Next-Morning Physical Performance, Cognitive Function, and Postural Sway in Adult Males: A Randomized, Placebo-Controlled, Crossover Study
    Morrison, Matthew
    Weakley, Jonathon
    Roach, Gregory D.
    Sargent, Charli
    Miller, Dean J.
    Nyman, Lara
    Gardiner, Carissa
    Munteanu, Gabriella
    Pahnke, Matthew D.
    Halson, Shona L.
    INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM, 2025,
  • [24] Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy SubjectsA 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study
    Gary G. Kay
    David R. Staskin
    Scott MacDiarmid
    Marilyn McIlwain
    Naomi V. Dahl
    Clinical Drug Investigation, 2012, 32 : 707 - 714
  • [25] Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercise-induced muscle damage: a randomized, repeated-dose, placebo-controlled study
    Allen, GJ
    Hartl, TL
    Duffany, S
    Smith, SF
    VanHeest, JL
    Anderson, JM
    Hoffman, JR
    Kraemer, WJ
    Maresh, CM
    PSYCHOPHARMACOLOGY, 2003, 166 (03) : 228 - 233
  • [26] Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercise-induced muscle damage: a randomized, repeated-dose, placebo-controlled study
    George J. Allen
    Tamara L. Hartl
    Shannon Duffany
    Stefanie F. Smith
    Jaci L. VanHeest
    Jeffrey M. Anderson
    Jay R. Hoffman
    William J. Kraemer
    Carl M. Maresh
    Psychopharmacology, 2003, 166 : 228 - 233
  • [27] Randomized, double-blinded, placebo-controlled phase I study of the pharmacokinetics, pharmacodynamics, and safety of KL130008, a novel oral JAK inhibitor, in healthy subjects
    Li, Na
    Du, Shuangqing
    Wang, Ying
    Zhu, Xiaohong
    Shu, Shiqing
    Men, Yuchun
    He, Miao
    Fang, Fang
    Wang, Yongsheng
    Gong, Yimou
    Chen, Jing
    Gu, Liling
    Cheng, Yezhe
    He, Qiang
    Lu, Huifang
    Niu, Yuanyuan
    Xu, Ying
    Feng, Ping
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 176
  • [28] Safety and Pharmacokinetics of a Novel Formulation of Human Apolipoprotein A-I (CSL112) in Healthy Subjects: Results of a Placebo-Controlled, Randomized Multiple Ascending Dose Study
    Easton, Rachael
    Tremper, Louise
    Shear, Charles
    CIRCULATION, 2012, 126 (21)
  • [29] A randomized double-blind placebo-controlled 3-way crossover study investigating psychomotor and cognitive residual effects of a new zolpidem modified-release formulation in healthy volunteers.
    Blin, O
    Micallef-Rolle, J
    Legangeux, E
    Zobouyan, I
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P27 - P27
  • [30] A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin
    Sampalis, John S.
    Brownell, Lidia Alfaro
    NUTRITION JOURNAL, 2012, 11
12345